Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study will assess the effectiveness of venlafaxine XR, randomized to either venlafaxine
XR or placebo in preventing the relapse of generalized anxiety disorder after 6 months of
treatment versus 12 months of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Norepinephrine Serotonin Serotonin and Noradrenaline Reuptake Inhibitors Venlafaxine Hydrochloride